Personalis (PSNL) News Today $4.89 +0.11 (+2.30%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Personalis publishes results from TRACERx lung cancer study in Nature MedicineJanuary 14, 2025 | markets.businessinsider.comLake Street Sticks to Their Buy Rating for Personalis (PSNL)January 13, 2025 | markets.businessinsider.comNew Nature Medicine Publication Shows ctDNA Levels Linked to Recurrence Risk in Lung CancerJanuary 13, 2025 | businesswire.comLake Street Capital Forecasts Strong Price Appreciation for Personalis (NASDAQ:PSNL) StockJanuary 11, 2025 | americanbankingnews.comBuy Rating for Personalis Driven by Strong Biopharma Revenue Growth and Promising Future ProspectsJanuary 9, 2025 | markets.businessinsider.comTD Cowen Reaffirms Their Buy Rating on Personalis (PSNL)January 9, 2025 | markets.businessinsider.comPromising Outlook for Personalis: Buy Rating Supported by Strong Financial Performance and Strategic PositioningJanuary 9, 2025 | markets.businessinsider.comPersonalis (NASDAQ:PSNL) Price Target Raised to $9.00Lake Street Capital upped their price objective on shares of Personalis from $7.00 to $9.00 and gave the company a "buy" rating in a research note on Wednesday.January 8, 2025 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for Personalis (NASDAQ:PSNL)HC Wainwright reaffirmed a "buy" rating and set a $11.00 target price on shares of Personalis in a research report on Wednesday.January 8, 2025 | marketbeat.comNeedham & Company LLC Reaffirms "Buy" Rating for Personalis (NASDAQ:PSNL)Needham & Company LLC reissued a "buy" rating and set a $7.25 target price on shares of Personalis in a research report on Wednesday.January 8, 2025 | marketbeat.comPersonalis Reports Preliminary Fourth Quarter and Full Year 2024 RevenueJanuary 7, 2025 | finance.yahoo.comPersonalis up 3% at $6.15 after Q4 pre-announcement, FY24 guidance increaseJanuary 7, 2025 | markets.businessinsider.comStrong Performance and Strategic Investment Justify Buy Rating for PersonalisJanuary 7, 2025 | markets.businessinsider.comJane Street Group LLC Increases Stock Position in Personalis, Inc. (NASDAQ:PSNL)Jane Street Group LLC lifted its holdings in shares of Personalis, Inc. (NASDAQ:PSNL - Free Report) by 154.3% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 164,281 shares of the company's stock after buying an additional 99,671 shares during the perioJanuary 2, 2025 | marketbeat.comLocal vaccine biotech secures $50 million Merck investmentDecember 26, 2024 | bizjournals.comThe 16% return this week takes Personalis' (NASDAQ:PSNL) shareholders one-year gains to 159%December 26, 2024 | finance.yahoo.comLocal vaccine biotech secures $50M Merck investmentDecember 24, 2024 | bizjournals.comPersonalis (PSNL) Gets a Buy from BTIGDecember 22, 2024 | markets.businessinsider.comPersonalis Receives Buy Rating Amid Strategic Investments and Revenue Growth PotentialDecember 22, 2024 | markets.businessinsider.comLake Street Reaffirms Their Buy Rating on Personalis (PSNL)December 20, 2024 | markets.businessinsider.comPersonalis price target raised to $11 from $9 at H.C. WainwrightDecember 20, 2024 | markets.businessinsider.comPersonalis (NASDAQ:PSNL) Given New $11.00 Price Target at HC WainwrightHC Wainwright increased their target price on Personalis from $9.00 to $11.00 and gave the company a "buy" rating in a report on Friday.December 20, 2024 | marketbeat.comNeedham & Company LLC Reiterates Buy Rating for Personalis (NASDAQ:PSNL)Needham & Company LLC reissued a "buy" rating and set a $7.25 price objective on shares of Personalis in a research report on Friday.December 20, 2024 | marketbeat.comMerck Buys $50 Million of Personalis StockDecember 19, 2024 | marketwatch.comPersonalis Shares Surge After Merck's $50 Million InvestmentDecember 19, 2024 | marketwatch.comPersonalis Advances Business Strategy with Investment from Merck and Extends Collaboration with ModernaDecember 19, 2024 | finance.yahoo.comPersonalis (PSNL) Gets a Buy from Lake StreetDecember 17, 2024 | markets.businessinsider.comPersonalis and Tempus Expand Collaboration to BiopharmaDecember 16, 2024 | finance.yahoo.comJacobs Levy Equity Management Inc. Reduces Stock Position in Personalis, Inc. (NASDAQ:PSNL)Jacobs Levy Equity Management Inc. reduced its position in shares of Personalis, Inc. (NASDAQ:PSNL - Free Report) by 44.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 405,670 shares of the company's stock aDecember 8, 2024 | marketbeat.com166,788 Shares in Personalis, Inc. (NASDAQ:PSNL) Purchased by Walleye Capital LLCWalleye Capital LLC bought a new position in shares of Personalis, Inc. (NASDAQ:PSNL - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 166,788 shares of the company's stock, valued at approximately $897,December 7, 2024 | marketbeat.comPersonalis: Promising Growth in Biopharma Sales Amidst Strategic Challenges – Hold Rating MaintainedNovember 19, 2024 | markets.businessinsider.comGSA Capital Partners LLP Lowers Position in Personalis, Inc. (NASDAQ:PSNL)GSA Capital Partners LLP cut its holdings in shares of Personalis, Inc. (NASDAQ:PSNL - Free Report) by 70.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 124,082 shares of the company's stock after selling 302,7November 19, 2024 | marketbeat.comCathie Wood’s ARK Investment bought 266.8K shares of Personalis todayNovember 15, 2024 | markets.businessinsider.comFY2024 EPS Estimate for Personalis Decreased by AnalystPersonalis, Inc. (NASDAQ:PSNL - Free Report) - Equities research analysts at HC Wainwright decreased their FY2024 earnings estimates for shares of Personalis in a research note issued on Thursday, November 7th. HC Wainwright analyst S. Ramakanth now expects that the company will earn ($1.37) perNovember 11, 2024 | marketbeat.comPersonalis, Inc. (NASDAQ:PSNL) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | msn.comHere's Why We're Not Too Worried About Personalis' (NASDAQ:PSNL) Cash Burn SituationNovember 9, 2024 | finance.yahoo.comFY2028 EPS Estimates for Personalis Cut by HC WainwrightPersonalis, Inc. (NASDAQ:PSNL - Free Report) - Research analysts at HC Wainwright decreased their FY2028 earnings per share estimates for Personalis in a report issued on Thursday, November 7th. HC Wainwright analyst S. Ramakanth now anticipates that the company will post earnings per share of $0November 8, 2024 | marketbeat.comPersonalis, Inc. (NASDAQ:PSNL) Shares Bought by ARK Investment Management LLCARK Investment Management LLC increased its stake in Personalis, Inc. (NASDAQ:PSNL - Free Report) by 11.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,085,523 shares of the company's stock after purchasing an additNovember 8, 2024 | marketbeat.comPersonalis Reports Solid Q3 Growth and Raises Revenue OutlookNovember 8, 2024 | markets.businessinsider.comTD Cowen Remains a Buy on Personalis (PSNL)November 8, 2024 | markets.businessinsider.comKey Takeaways From Personalis Analyst RatingsNovember 8, 2024 | benzinga.comPersonalis Inc (PSNL) Q3 2024 Earnings Call Highlights: Robust Revenue Growth Amid Strategic ...November 8, 2024 | finance.yahoo.comNeedham & Company LLC Reiterates "Buy" Rating for Personalis (NASDAQ:PSNL)Needham & Company LLC restated a "buy" rating and set a $7.25 target price on shares of Personalis in a report on Thursday.November 7, 2024 | marketbeat.comPersonalis Reports Third Quarter 2024 Financial ResultsNovember 7, 2024 | businesswire.comPersonalis, Inc. (PSNL) Q3 2024 Earnings Call TranscriptNovember 6, 2024 | seekingalpha.comPersonalis Inc (PSNL) Q3 2024 Earnings Report Preview: What To ExpectNovember 5, 2024 | finance.yahoo.comPersonalis (NASDAQ:PSNL) Stock, Option ChainNovember 3, 2024 | benzinga.comPersonalis (PSNL) Set to Announce Earnings on WednesdayPersonalis (NASDAQ:PSNL) will be releasing earnings after the market closes on Wednesday, November 6, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=639156)October 30, 2024 | marketbeat.comThe Proper Play On PersonalisOctober 28, 2024 | seekingalpha.comPersonalis to Announce Third Quarter 2024 Financial ResultsOctober 23, 2024 | businesswire.com Get Personalis News Delivered to You Automatically Sign up to receive the latest news and ratings for PSNL and its competitors with MarketBeat's FREE daily newsletter. Email Address PSNL Media Mentions By Week PSNL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PSNL News Sentiment▼-0.080.44▲Average Medical News Sentiment PSNL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PSNL Articles This Week▼12▲PSNL Articles Average Week Get Personalis News Delivered to You Automatically Sign up to receive the latest news and ratings for PSNL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AGL News Today CDNA News Today PNTG News Today AVAH News Today CSTL News Today AUNA News Today GRAL News Today FLGT News Today TALK News Today INNV News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PSNL) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Personalis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Personalis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.